Showing 1 - 3 results of 3 for search 'C BUCCI-RECHTWEG', query time: 1.34s Refine Results
  1. 1
    LEChENIE BISFOSFONATAMI I PERELOMy PODVERTEL'NOY ILI DIAFIZARNOY OBLASTEY BEDRENNOY KOSTI

    LEChENIE BISFOSFONATAMI I PERELOMy PODVERTEL'NOY ILI DIAFIZARNOY OBLASTEY BEDRENNOY KOSTI by D. M. BLACK, M P KELLY, H. K. GENANT, L PALERMO, R EASTELL, C BUCCI-RECHTWEG, J CAULEY, P C. LEUNG, S BOONEN, A SANTORA, A DE PAPP, D. C. BAUER

    Published 2011-12-01
    Get full text
    Article
  2. 2
    The effect of 6-year osteoporosis treatment withzoledronic 5 mg (aclasta) in comparison with 3-yeartreatment: results from the horizon-pft.

    The effect of 6-year osteoporosis treatment withzoledronic 5 mg (aclasta) in comparison with 3-yeartreatment: results from the horizon-pft. by D Black, I. R. Reid, J. A. Cauley, S Boonen, F Cosman, P C Leung, P Lakatos, Z Man, S. R. Cummings, T. F. Hue, M. E. Ruzycky, R Martinez, G Su, C Bucci-Rechtweg, R Eastell

    Published 2011-04-01
    Get full text
    Article
  3. 3
    EFFECT OF 6-YEAR TREATMENT OF OSTEOPOROSIS WITH ZOLEDRONIC ACID 5MG (ACLASTA) COMPARED WITH THE 3-YEAR-TREATMENT, RESULTS OF EXTENDED HORIZON PFT STUDY

    EFFECT OF 6-YEAR TREATMENT OF OSTEOPOROSIS WITH ZOLEDRONIC ACID 5MG (ACLASTA) COMPARED WITH THE 3-YEAR-TREATMENT, RESULTS OF EXTENDED HORIZON PFT STUDY by D M Black, I R Reid, S Boonen, C Bucci-Rechtweg, J A Cauley, F Cosman, S R Cummings, T F Hue, K Lippuner, P Lakatos, P C Leung, Z Man, R Martinez, M Tan, M E Ruzycky, G Su, R Eastell

    Published 2012-04-01
    Get full text
    Article

Search Tools: